- 期刊
Anti-Müllerian Hormone as a Sensitive Marker of Ovarian Function in Young Cancer Survivors
延伸閱讀
- Walentowicz, P., Sadlecki, P., Krintus, M., Sypniewska, G., Cyl, A., Grabiec, M., & Sadlecka, M. W. (2013). Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer. International Journal of Endocrinology, 2013(), 871-876-099. https://doi.org/10.1155/2013/517239
- Wei, N. (2008). Oestrogen receptor subtypes in ovarian cancer [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200014154
- Sawada, K., Hara, C. O., Kimura, T., & Morishige, K. I. (2012). Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer. Journal of Oncology, 2012(), 281-286-126. https://doi.org/10.1155/2012/915140
- Misganaw, B., Ahsen, E., Singh, N., Baggerly, K. A., Unruh, A., White5, M. A., & Vidyasagar, M. (2015). Optimized Prediction of Extreme Treatment Outcomes in Ovarian Cancer. Cancer Informatics, (2015-S5), 45-55. https://doi.org/10.4137/CIN.S30803
- Khaleel, A. (2012). Investigating the Roles of microRNAs in Human Ovarian Cancer [master's thesis, National Chiao Tung University]. Airiti Library. https://doi.org/10.6842/NCTU.2012.00305